These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2926064)

  • 21. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
    Gulamhusein S; Ko P; Carruthers SG; Klein GJ
    Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
    Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
    N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome.
    Cosio FG; Benson DW; Anderson RW; Hession WT; Pritzker MR; Kriett JM; Benditt DG
    Am J Cardiol; 1982 Aug; 50(2):353-9. PubMed ID: 7102563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?
    Fujimura O; Klein GJ; Yee R; Sharma AD
    J Am Coll Cardiol; 1990 Apr; 15(5):1082-6. PubMed ID: 2312962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Assessment of Accessory Pathway Function in Patients with Wolff-Parkinson-White Syndrome.
    Rigos LJ; Fishbein JS; Blaufox AD
    Pediatr Cardiol; 2020 Aug; 41(6):1212-1219. PubMed ID: 32529357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxysmal atrial flutter and fibrillation associated with preexcitation syndrome: treatment with ajmaline.
    Sclarovsky S; Kracoff OH; Strasberg B; Lewin RF; Agmon J
    Am J Cardiol; 1981 Nov; 48(5):929-33. PubMed ID: 7304440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
    Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
    J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency catheter ablation of accessory pathways during pre-excited atrial fibrillation: acute success rate and long-term clinical follow-up results as compared to those patients undergoing successful catheter ablation during sinus rhythm.
    Kose S; Amasyali B; Aytemir K; Can I; Kilic A; Kursaklioglu H; Iyisoy A; Isik E
    Heart Vessels; 2005 Jul; 20(4):142-6. PubMed ID: 16025362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
    Pappone C; Vicedomini G; Manguso F; Baldi M; Pappone A; Petretta A; Vitale R; Saviano M; Ciaccio C; Giannelli L; Calovic Z; Tavazzi L; Santinelli V
    Circulation; 2012 Feb; 125(5):661-8. PubMed ID: 22215859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome.
    Bromberg BI; Lindsay BD; Cain ME; Cox JL
    J Am Coll Cardiol; 1996 Mar; 27(3):690-5. PubMed ID: 8606283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
    Strasberg B; Sagie A; Rechavia E; Katz A; Ovsyscher IA; Sclarovsky S; Agmon J
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):801-6. PubMed ID: 2488095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Morady F; DiCarlo LA; Baerman JM; De Buitleir M
    Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways.
    Piotrowski R; Kryński T; Baran J; Futyma P; Stec S; Kułakowski P
    Cardiol J; 2014; 21(3):299-303. PubMed ID: 23990192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal-averaged P wave in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation.
    Maia IG; Cruz Filho FE; Fagundes ML; Boghossian SH; Vanheusden L; Sa RM; Alves PA
    J Am Coll Cardiol; 1995 Nov; 26(5):1310-4. PubMed ID: 7594048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propafenone in Wolff-Parkinson-White syndrome at risk.
    Santinelli V; Turco P; De Paola M; Smimmo D; Giasi M; Santinelli C; Chiariello M; Condorelli M
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):681-5. PubMed ID: 2076378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient appearance of antegrade conduction via an AV accessory pathway caused by atrial fibrillation in a patient with intermittent Wolff-Parkinson-White syndrome.
    Niwano S; Kitano Y; Moriguchi M; Izumi T
    Heart; 2000 May; 83(5):E8. PubMed ID: 10768920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.